A randomised trial of mastectomy only versus tamoxifen for treating elderly patients with operable primary breast cancer-Final results at 20-year follow-up

Critical Reviews in Oncology/Hematology

Volumn 78, Issue 3, 2011, Pages 260-264

  Chakrabarti, J ^a   Kenny, F S ^a   Syed, B M ^a   Robertson, J F R ^a   Blamey, R W ^a   Cheung, K L ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Breast cancer; Elderly; Local failure; Primary endocrine therapy; Randomised trial; Survival

Indexed keywords

TAMOXIFEN;

AGED; BREAST CANCER; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MASTECTOMY; OVERALL SURVIVAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; WEDGE RESECTION;

AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; PILOT PROJECTS; SURVIVAL ANALYSIS; TAMOXIFEN;

EID: 84879198564     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2010.04.006     Document Type: Review

References (14)

1. Diab S.G., Elledge R.M., Clark G.M. Tumor characteristics and clinical outcome of elderly women with breast cancer. Journal of the National Cancer Institute 2000, 92:550-556.
2. Cheung K., Wong A., Parker H., et al. Pathological features of primary breast cancer in the elderly based on needle core biopsies-a large series from a single centre. Critical Reviews in Oncology-Hematology 2008, 67:263-267.
3. Preece P., Wood R., Mackie C., et al. Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study. British Medical Journal 1982, 284:869-870.
4. Bergman L., van Dongen J., van Ooijen B., et al. Should tamoxifen be a primary treatment choice for elderly breast cancer patients with locoregional disease?. Breast Cancer Research and Treatment 1995, 34:77-83.
5. Mustacchi G., Milani S., Pluchinotta A., et al. Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: the GRETA Trial Group for Research on Endocrine Therapy in the Elderly. Anticancer Research 1994, 14:2197-2200.
6. Willsher P., Robertson J., Jackson L., et al. Investigation of primary tamoxifen therapy for elderly patients with operable breast cancer. Breast 1997, 6:150-154.
7. Kenny F., Robertson J., Ellis I., et al. Long-term follow-up of elderly patients randomised to primary tamoxifen or wedge mastectomy as initial therapy for operable breast cancer. Breast 1998, 7:335-339.
8. Hayward J., Carbone P., Heuson J., et al. Assessment of response to therapy in advanced breast cancer. Cancer 1977, 39:1289-1293.
9. Al-Khyatt W., Syed B., Morgan D., et al. Primary endocrine therapy for early operable primary breast cancer in elderly women: a large series from a single institution. Journal of Clinical Oncology ASCO Annual Meeting Proceedings 2009, 27(15S):630.
10. Al-Hilaly M., Willsher P., Robertson J., et al. Audit of a conservative management policy of the axilla in elderly patients with operable breast cancer. European Journal of Surgical Oncology 1997, 339-340.
11. Bates T., Riley D., Houghton J., et al. Breast cancer in elderly women: a Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. British Journal of Surgery 1991, 78:591-594.
12. Fennessy M., Bates T., MacRae K., et al. Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer. British Journal of Surgery 2004, 91:699-704.
13. Hind D, Wyld L, Beverley CB, et al. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus). Cochrane Database of Systematic Reviews 2006:CD004272.
14. Syed B., Johnston S., Wong D., et al. Surgery versus primary endocrine therapy for elderly women with oestrogen receptor positive early operable primary breast cancer-survival analysis and correlation with oestrogen receptor positivity. Journal of Clinical Oncology ASCO Annual Meeting Proceedings I 2009, 27(15S):612.